As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings. To address the rising demand for better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved therapies some of which fall within the bounds of pain management therapeutics.
Pain management market is one of the emerging fields within the pharmaceutical industry. Pain is one of the key associated symptoms in various medical conditions, and can potentially interpose with one’s quality of life and day-to-day working schedule. Three major variants of pain include nociceptive, neuropathic and inflammatory, while the duration can vary from acute to chronic. Furthermore, for placating various painful conditions different treatment regimes are followed, and the most commonly used drug classes for alleviating pain include local analgesics, NSAIDs and opioids.
This report provides a comprehensive overview of the global market covering various geographic regions. The pain management realm is intensely competitive with numerous global and domestic corporations holding the reins of the same. The leading industry players include Pfizer, Eli Lilly, Novartis and J&J. In addition to the industry competition, product contention is also intense as numerous innovative, novel and highly effective therapeutic variants are available in the market. Furthermore, market dynamics viz., key trends and industry developments, growth drivers and the challenges faced by the industry are discussed in detail.